Find More Contacts for Kymab
Protected Content
VP
VP Management
1 email found
View contacts for Kymab to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@kymab.com
  • Phone Number 44 1223 833301

Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics with a focus on immune-mediated diseases and immuno-oncology using its proprietary, integrated platforms collectively called IntelliSelect®. Kymab’s IntelliSelect Transgenic platforms contain a full diversity of human antibodies, making them

the most comprehensive antibody platforms available.

The company was founded in 2010 and is based in Cambridge, the United Kingdom.

Lists Featuring This Company

Biopharma Companies
4,072 Number of Organizations • $167.8B Total Funding Amount • 8,523 Number of Investors
Therapeutics Companies With More Than $1M in Revenue (Top 10K)
9,649 Number of Organizations • $217.7B Total Funding Amount • 10,742 Number of Investors
Acquired Biopharma Companies
448 Number of Organizations • $41.3B Total Funding Amount • 1,423 Number of Investors
Biotechnology Acquired Companies With More Than $1M in Revenue
1,448 Number of Organizations • $106.9B Total Funding Amount • 4,499 Number of Investors
Kymab was acquired by Sanofi for $1.1B on Jan 11, 2021.

Frequently Asked Questions

Where is Kymab's headquarters? Kymab is located in Cambridge, Cambridgeshire, United Kingdom.Who invested in Kymab? Kymab has 6 investors including Bill & Melinda Gates Foundation and Malin Corporation.How much funding has Kymab raised to date? Kymab has raised .When was the last funding round for Kymab? Kymab closed its last funding round on Jan 10, 2017 from a Grant round.Who are Kymab's competitors? Alternatives and possible competitors to Kymab may include MerusAclaris Therapeutics, and CureVac.